TradingView
AlenCiken
25 ott 2018 09:58

EU regulators greenlight U.S. biotech Aveo's kidney cancer drug 

NASDAQ:AVEO1D

Descrizione

⋅
reuters.com/article/us-aveo-tivozanib-kindeycancer/eu-regulators-greenlight-u-s-biotech-aveos-kidney-cancer-drug-idUSKBN19E1BL

fiercebiotech.com/biotech/aveo-soars-as-long-beleaguered-cancer-drug-nears-approval

Trend AnalysisHarmonic PatternsChart Patterns
Altro